1. Centers for Disease Control and Prevention. Ebola Hemorrhagic Fever. http://www.cdc.gov/vhf/ebola/outbreaks/guinea/ [Cited 11 December 2014]. 2. Centers for Disease Control and Prevention. Ebola Hemorrhagic Fever. http://www.cdc.gov/vhf/ebola/treatment/index.html [Cited 11 December 2014]. 3. Centers for Disease Control and Prevention. Ebola Hemorrhagic Fever. http://www.cdc.gov/vhf/ebola/outbreaks/guinea/qa-experimental-treatments.html [Cited 11 December 2014].
Alang, N. (2015). Using the Untested Ebola Drug in Ebola Affected Patients: An Ethical Dilemma. International Journal of Travel Medicine and Global Health, 3(1), 1-1. doi: 10.20286/ijtmgh-03013
MLA
Neha Alang. "Using the Untested Ebola Drug in Ebola Affected Patients: An Ethical Dilemma". International Journal of Travel Medicine and Global Health, 3, 1, 2015, 1-1. doi: 10.20286/ijtmgh-03013
HARVARD
Alang, N. (2015). 'Using the Untested Ebola Drug in Ebola Affected Patients: An Ethical Dilemma', International Journal of Travel Medicine and Global Health, 3(1), pp. 1-1. doi: 10.20286/ijtmgh-03013
VANCOUVER
Alang, N. Using the Untested Ebola Drug in Ebola Affected Patients: An Ethical Dilemma. International Journal of Travel Medicine and Global Health, 2015; 3(1): 1-1. doi: 10.20286/ijtmgh-03013